1 |
Anglim PP, Alonzo TA, Laird-Offringa IA (2008). DNA methylation-based biomarkers for early detection of nonsmall cell lung cancer: an update. Mol Cancer, 7, 81.
DOI
|
2 |
Kitkumthorn N, Keelawat S, Rattanatanyong P, et al (2012). LINE-1 and Alu methylation patterns in lymph node metastases of head and neck cancers. Asian Pac J Cancer Prev, 13, 4469-75.
DOI
|
3 |
Patel A, Groopman JD, Umar A (2003). DNA methylation as a cancer-specific biomarker: from molecules to populations. Ann N Y Acad Sci, 983, 286-97.
DOI
|
4 |
Patel V, Martin D, Malhotra R, et al (2013). DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays. Oral Oncol, 49, 93-101.
DOI
|
5 |
Payne SR, Serth J, Schostak M, et al (2009). DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for noninvasive detection. Prostate, 69, 1257-69.
DOI
|
6 |
Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S, et al (2006). SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med (Berl), 84, 175-82.
DOI
|
7 |
Safar AM, Spencer H, Su X, et al (2007). Promoter hypermethylation for molecular nodal staging in non-small cell lung cancer. Arch Pathol Lab Med, 131, 936-41.
|
8 |
Vinayanuwattikun C, Chantranuwat P, Sriuranpong V, et al (2014).The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence. Int J Clin Oncol, 19, 586-92.
DOI
|
9 |
Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, et al (2011). Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer. J Thorac Oncol, 6, 1818-25.
DOI
|
10 |
Vinayanuwattikun C, Winayanuwattikun P, Chantranuwat P, et al (2013). The impact of non-tumor-derived circulating nucleic acids implicates the prognosis of non-small cell lung cancer. J Cancer Res Clin Oncol, 139, 67-76.
DOI
|
11 |
Kim MS, Lee J, Sidransky D (2010). DNA methylation markers in colorectal cancer. Cancer Metastasis Rev, 29, 181-206.
DOI
|
12 |
Brock MV, Hooker CM, Ota-Machida E, et al (2008). DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med, 358, 1118-28.
DOI
|
13 |
Chujan S, Kitkumthorn N, Siriangkul S, et al (2014). CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions. Asian Pac J Cancer Prev, 15, 7971-5.
DOI
|
14 |
Huynh KT, Hoon DS (2012). Epigenetics of regional lymph node metastasis in solid tumors. Clin Exp Metastasis, 29, 747-56.
DOI
|
15 |
Toyooka S, Toyooka KO, Maruyama R, et al (2001). DNA methylation profiles of lung tumors. Mol Cancer Ther, 1, 61-7.
|
16 |
Tiwawech D, Srisuttee R, Rattanatanyong P, et al (2014). Alu methylation in serum from patients with nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 9797-800.
DOI
|